AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| THL | Ann: Ongoing Disclosure Notices – Multiple | 18/04/18 | 0 | 22 | |||
|
|||||||
| THL | Ann: THL - Notification of allotment of securities | 16/04/18 | 0 | 30 | |||
|
|||||||
| THL | Ann: THL - Dividend Reinvestment Plan Strike Price | 12/04/18 | 0 | 34 | |||
|
|||||||
| THL | Ann: Ongoing Disclosure Notices – Multiple | 05/04/18 | 0 | 44 | |||
|
|||||||
| THL | Ann: D&O Ongoing Disclosures - Multiple | 04/04/18 | 0 | 40 | |||
|
|||||||
| THL | Ann: Ongoing Disclosure Notices – Multiple | 04/04/18 | 0 | 23 | |||
|
|||||||
| THL | Ann: Notification of Issue of Securities - LTI Scheme | 03/04/18 | 0 | 33 | |||
|
|||||||
| THL | Ann: Conversion of Redeemable Ordinary Shares to Ordinary Shares | 03/04/18 | 0 | 26 | |||
|
|||||||
See All Discussions
NZX News